Pro Medicus (PME.AX) Aktsia Kursus

Pro Medicus Kursus

ASX·SULETUD
184,83
​
Turg suletud

Käive kasvas 17,3 % aastas viimase 19 aasta jooksul 261,69 M AUD-ni. Kasum aktsia kohta kasvas 20,8 % aastas viimase 19 aasta jooksul. Pro Medicus netomarginaal on nüüd 101,4 %, tõusnud 47,6 %-lt mõni aasta tagasi. Pro Medicus pakub praegu umbes 0,48 % dividenditootlust. Väljamaksesuhe on umbes 73 % kasumist. Dividend kasvas 21,6 % aastas viimase 19 aasta jooksul. Analüütikute hinnasihi mediaan on 244,80 AUD, st üle praegust hinda 32,4 %. 17 analüütikust 11 soovitab osta — üldine konsensus on Osta.

Pro Medicus aktsiahinnad

Hangi need andmed Eulerpool API kaudu

100 000 päringut/kuus tasuta · krediitkaarti pole

Pro Medicus ärimudel ja aktsia analüüs

Pro Medicus Ltd. on Austraalia ettevõte, mis spetsialiseerub meditsiinilise kujutlussoftware lahenduste arendamisele ja turustamisele. Ettevõte asutati 1983. aastal ja selle peakontort asub Melbournes.

Korduma kippuvad küsimused Pro Medicus aktsia kohta

The business model of Pro Medicus Ltd revolves around providing advanced healthcare imaging software solutions. The company specializes in developing and delivering a comprehensive range of radiology solutions that enhance workflow efficiency and improve patient care. Pro Medicus offers cutting-edge products like Visage AI, Visage 7, and Visage RIS, which allow healthcare professionals to efficiently manage and analyze medical images. By combining innovative technology with a customer-centric approach, Pro Medicus helps healthcare providers worldwide optimize their imaging operations and deliver accurate diagnoses. With its focus on developing state-of-the-art software solutions, Pro Medicus positions itself as a leader in the medical imaging industry.

Pro Medicus Ltd is primarily active in the healthcare industry.

The main competitors of Pro Medicus Ltd in the market include other medical imaging companies such as Carestream Health, Change Healthcare, and Sectra AB. These companies also specialize in providing medical imaging solutions and technology to healthcare providers and are prominent players in the industry. Pro Medicus Ltd competes with them in terms of product offerings, innovation, customer base, and market share.

Pro Medicus Ltd is a renowned healthcare imaging and information technology provider. Established in 1983, the company has a rich history of pioneering innovative solutions in the medical imaging industry. With a strong focus on radiology, Pro Medicus has developed advanced imaging software that improves efficiency and enhances patient care. The company's success is attributed to its commitment to research and development, resulting in cutting-edge technologies and multiple industry awards. Pro Medicus operates globally, serving prominent healthcare institutions and professionals. With its profound expertise and dedication to advancing medical imaging technology, Pro Medicus Ltd continues to lead the industry in providing innovative solutions for the healthcare sector.

Some significant milestones achieved by Pro Medicus Ltd include the successful expansion into major global markets, such as the United States and Europe, further solidifying its position as a leading provider of healthcare imaging solutions. The company has also experienced continuous revenue growth, achieving record-breaking financial results year after year. Pro Medicus Ltd has consistently developed and released innovative software solutions, enhancing efficiency and productivity for healthcare professionals. Additionally, the company has formed strategic partnerships with top-tier healthcare organizations, further establishing its reputation as a trusted industry leader. These accomplishments have propelled Pro Medicus Ltd's growth and success in the competitive healthcare technology sector.

Pro Medicus Ltd primarily operates in Australia and the United States.

Pro Medicus Ltd is a leading healthcare IT solutions provider with a strong commitment to excellence and innovation. The company's core values revolve around delivering exceptional products and services that empower healthcare professionals to enhance patient care and outcomes. Pro Medicus emphasizes a customer-centric approach and strives to provide customized solutions tailored to meet the unique needs of its clients. With a clear focus on technological advancements and high-quality imaging software, Pro Medicus constantly pushes the boundaries in the healthcare industry. By fostering a culture of collaboration and continuous improvement, Pro Medicus Ltd is dedicated to transforming the way medical images are managed and shared worldwide.

Analüütikud määravad Pro Medicus aktsiale keskmiseks hinnasihi 226,59 AUD (mediaan: 244,80 AUD), mis on +22,6 % viimase hinna suhtes. Konsensus põhineb 17 analüütiku hinnangul.

17 analüütikut hindavad praegu Pro Medicus aktsiat: 13 soovitab osta, 4 hoida ja 0 müüa.

Praeguse kursiga kaubeldakse Pro Medicus aktsiaga 115,61 EUR (184,83 AUD) juures.

Pro Medicus aktsia (PME.AX) on noteeritud 3 börsil, sh: ASX (PME.AX), Frankfurt (PMC.F).

Pro Medicus Ltd is a global company specializing in providing advanced IT solutions for the healthcare industry. They offer innovative information and image management solutions that are used by leading healthcare organizations worldwide. Their main divisions include Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), and Telemedicine. Their PACS solutions allow hospitals and healthcare organizations to store, manage, and share digital images from medical diagnostic devices such as CT, MRI, and X-ray machines. These solutions are scalable and provide high-quality image quality for radiologists and other specialists to make informed diagnoses. Their RIS is an integrated solution designed specifically for radiology departments and practices, providing complete patient and order management, as well as integrated workflow tools to improve the efficiency and accuracy of diagnosing and evaluating medical imaging data. Their telemedicine solutions enable radiology professionals to edit and share medical images remotely over the internet, particularly beneficial in facilities with limited resources or for quick access to medical images in emergency diagnoses. In addition, Pro Medicus Ltd also offers specialized solutions for clinical decision support, automated medical image analysis, and patient management. Their clinical decision support provides assistance to medical professionals in diagnosis and treatment monitoring, while the automated analysis of medical image data allows for the quick processing of large amounts of data, producing results that can be utilized by professionals for diagnostic purposes. Their patient management solutions provide comprehensive capture and management of health data that can be used by doctors and other professionals to develop better treatment options for their patients. Pro Medicus Ltd is a global company with a strong focus on research and development. They have partnerships with leading healthcare organizations worldwide and possess a strong portfolio of intellectual property. Their business model is based on the sale of products and services specifically designed for the needs of the healthcare industry. The company emphasizes innovation, customer satisfaction, and delivering high-quality solutions that are scalable and flexible for various users. Overall, Pro Medicus Ltd is an innovative market leader in the field of medical IT solutions. They are globally recognized for their products and services and are expected to continue playing a significant role in the healthcare industry.

Pro Medicus käive on 261,69 M AUD. See näitaja põhineb praegusel finantsandmetel ja peegeldab ettevõtte äritulemuseid.

Pro Medicus kasum on 265,34 M AUD. Netokasum peegeldab ettevõtte kasumlikkust pärast kõigi kulude mahaarvamist.

Võrdlusarvud hinna ja kasumiga (P/E) Pro Medicus jaoks on praegu 72,89. P/E-suhtarv võrdleb praegust aktsiahinnad kasumiga aktsia kohta ja aitab investoritel hinnata Pro Medicus aktsia väärtust.

Kursuse ja müügimahu suhe (P/S) Pro Medicus jaoks on praegu 73,91. P/S-suhtarv võrdleb börsikapitalisatsooni aastase tuluga ja teenib hindamismõõdikuna Pro Medicus aktsia jaoks.

Eulpooli kvaliteedinäitaja Pro Medicus jaoks on 8/10.

Pro Medicus ISIN on AU000000PME8. ISIN (rahvusvaheline väärtpaberi identifitseerimise number) on väärtpaberite globaalne unikaalne tuvastaja.

Pro Medicus WKN on 591723. WKN (Wertpapierkennnummer) on kuuekohaline saksa väärtpaberi identifitseerimise number.

Pro Medicus ticker on PME.AX. Ticker-sümbol kasutatakse Pro Medicus aktsiate kauplemiseks börsil.

Õiglane väärtusTerminal
166,35 AUD
Üle-/alahinnangTerminal
Õiglaselt hinnatakse
Tööstus
Tervishoitehonoloogia
Aktsiate arv
Töötajad
Tulu töötaja kohta
3,31 M AUD
Tulukasvu keskmine 5 aastat
EBIT kasvu keskmine 5 aastat
Puhaskasumi kasvu keskmine 5 aastat
Veebisait promed.com.au
Riik
Austraalia
Valuuta
AUD
Börsi noteerimise algus
10. okt 2000
ISIN
AU000000PME8
CUSIP
Q77301101
SEDOL
6292782
Turukapitalisatsioon
19,34 B AUDLarge Cap
52-nädala vahemik
PEG
10,77
P/E suhe
P/E e 2027
101,76
P/E e 2028
80,72
P/E e 2029
65,60
P/E e 2030
47,79
P/E e 2031
73,35
P/S e
57,13
EV/EBIT
98,64
P/B suhe
42,90
ROE (omakapitali tootlus)
ROA (varatootlus)
ROCE (kasutatud kapitali tootlus)
ROIC (investeeritud kapitali tootlus)
58,85 %
Dividend
Dividendi tootlus
0,48 %
Prognoositud dividendi tootlus
0,40 %
Väljamaksmise suhe
72,54 %
Dividendi kasv Ø5Y
23,03 %
Dividendimaksed aastas
2
Dividend makstud alates
14 aastat
Dividenti ei ole vähendatud alates
10 aastat
Dividenti on suurendatud alates
10 aastat
Dividendi mahaarvamismaks
30,00 %
Viimati värskendatud 22. okt 2026, 20:02

Pro Medicus Börsiticker

ASX · PME.AXFRANKFURT · PMC.FOTC · PMCUF

Pro Medicus FIGI

PME:AU · BBG000C41MZ9PME:AT · BBG000C41NB3PMCUF:US · BBG000H06487PMCUF:UV · BBG000H07L06PME:AH · BBG002F3J5Y3PMC:GR · BBG00GCTJN24PMC:GF · BBG00GCTJN33PMEEUR:EO · BBG00GD4N8Z0PMEEUR:XH · BBG00GD4N924PMEEUR:XF · BBG00GD4N942PMEEUR:XE · BBG00GD4N960PMEEUR:XJ · BBG00GD4N979

Kõik teised näitajad ja analüüsid Pro Medicus kohta sügavamalt

Meie Pro Medicus-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes Pro Medicus. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse: